Kim Kamdar

Kim Kamdar

Vorsitzender bei SERA PROGNOSTICS, INC.

Vermögen: 129 189 $ am 31.05.2024

56 Jahre
Health Technology
Finance
Health Services

Profil

Kim Puloma Kamdar is the founder of Truvian Sciences, Inc. (founded in 2015) and holds the title of Chairman.
Dr. Kamdar is also the founder of Aryzun Pharmaceuticals and Seraphina Therapeutics, Inc. Dr. Kamdar's current job(s) include Chairman at Sera Prognostics, Inc. (since 2011), Director at ROX Medical, Inc., One Palmer Square Associates VII LLC, The Hastings Center, Epic Sciences, Inc., Connect Foundation, SalveoDx, Independent Director at Evofem Biosciences, Inc. (since 2018), Independent Director at Singular Genomics Systems, Inc. (since 2017), Director at Alume Biosciences, Inc. (since 2020), Director & Partner at Epitel, Inc., Director at Access Youth Academy, Pleno, Inc., Director at Alumne Elearning SL, Partner at Domain Associates LLC (since 2005), Managing Member at One Palmer Square Associates VIII LLC, Partner at Domain LLC (since 2011), Advisory Partner at Adjuvant Capital LP, and Managing Partner at Medical Excellence Capital LLC (since 2021).
Dr. Kamdar's former job(s) include Chairman & Chief Executive Officer at Aspen Neuroscience, Inc., Chairman at Obalon Therapeutics, Inc. (from 2008 to 2021), Director at Corthera, Inc., Research Director at Novartis International AG, Director at Achaogen, Inc., Director at BiPar Sciences, Inc., Director at Adastra Pharmaceuticals, Inc., Independent Director at Syndax Pharmaceuticals, Inc. (from 2006 to 2017), Director at Omniome LLC, Director at Sonexa Therapeutics, Inc., Director at Nuon Therapeutics, Inc., Director at Altair Therapeutics, Inc., Director at Neothetics, Inc. (from 2011 to 2014), Director at Ariosa Diagnostics, Inc. (from 2010 to 2015), Director at San Diego Venture Group, Principal at MPM BioImpact, Inc (from 2003 to 2004), Program Leader at Torrey Mesa Research Institute, and Advisor at Bill & Melinda Gates Foundation.
Dr. Kamdar obtained a doctorate degree from Emory University in 1995 and an undergraduate degree from Northwestern University in 1988.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
06.06.2024 13 746 ( 0,04% ) 123 714 $ 31.05.2024
29.05.2024 15 000 ( 0,02% ) 5 475 $ 31.05.2024

Aktive Positionen von Kim Kamdar

UnternehmenPositionBeginn
SERA PROGNOSTICS, INC. Vorsitzender 08.06.2023
EVOFEM BIOSCIENCES, INC. Direktor/Vorstandsmitglied 01.01.2018
SINGULAR GENOMICS SYSTEMS, INC. Direktor/Vorstandsmitglied 01.05.2017
Private Equity Investor 01.01.2005
Direktor/Vorstandsmitglied -
Connect Foundation Direktor/Vorstandsmitglied -
Berater -
Gründer -
Direktor/Vorstandsmitglied 01.01.2020
░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ -
░░░░░░░ ░░░░░░░░░░ ░░░░░░░ ░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ -
Alle aktiven Positionen von Kim Kamdar

Ehemalige bekannte Positionen von Kim Kamdar

UnternehmenPositionEnde
░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Kim Kamdar im Detail an

Ausbildung von Kim Kamdar

Emory University Doctorate Degree
Northwestern University Undergraduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Kim Kamdar im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

42

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen4
SYNDAX PHARMACEUTICALS, INC.

Health Technology

SERA PROGNOSTICS, INC.

Health Services

EVOFEM BIOSCIENCES, INC.

Health Technology

SINGULAR GENOMICS SYSTEMS, INC.

Health Technology

Private Unternehmen36

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Finance

Finance

Health Technology

One Palmer Square Associates VII LLC

Health Technology

Health Technology

Finance

Distribution Services

Health Technology

One Palmer Square Associates VIII LLC

Aryzun Pharmaceuticals

Health Services

The Hastings Center

Health Technology

Finance

Connect Foundation

SalveoDx

Health Services

Health Services

Commercial Services

Finance

Technology Services

Commercial Services

Consumer Services

Health Services

Technology Services

Technology Services

Finance

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Kim Kamdar